Patent US4501752A successfully refreshed from Google Patents.
US4501752A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antiulcer drug
Assignee: SSP Co Ltd
•
Filing: 1983-04-22
•
Granted: 1985-02-26
•
Expires: 2003-04-22
Abstract
Abstract An antiulcer drug comprising Ikarugamycin as its active ingredient is disclosed.
Inventors
- 👤 Koichi Yokoi
- 👤 Koichi Tachibana
- 👤 Kazuo Isomae
- 👤 Toshiaki Nakashima
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 05:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61P; A61P1/00; A61P1/04
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
21 words
An antiulcer drug comprising: (a) an antiulcer effective amount of Ikarugamycin of the following formula: ##STR3## (b) a pharmaceutical acceptable excipient.
Claim 2
Dependent Claim
21 words
An antiulcer drug comprising: (a) an antiulcer effective amount of Ikarugamycin of the following formula: ##STR3## (b) a pharmaceutical acceptable excipient.
Claim 3
Independent Claim
24 words
A method for treating or preventing ulcers which comprises administering to animals or humans in need of said treatment an effective amount of Ikarugamycin.
Claim 4
Independent Claim
24 words
A method for treating or preventing ulcers which comprises administering to animals or humans in need of said treatment an effective amount of Ikarugamycin.
Claim 5
Dependent Claim
13 words
The antiulcer drug of claim 1 in a form suitable for oral administration.
Claim 6
Dependent Claim
16 words
The antiulcer drug of claim 3, in the form of a tablet, capsule, granules or syrup.
Claim 7
Dependent Claim
20 words
The antiulcer drug of claim 1, wherein the excipient is selected from the group consisting of starch, lactose, and mannitol.
Claim 8
Dependent Claim
10 words
The antiulcer drug of claim 1, further comprising a binder.
Claim 9
Dependent Claim
22 words
The antiulcer drug of claim 6, wherein the binder is selected from the group consisting of carboxymethyl cellulose sodium and hydroxypropyl cellulose.
Claim 10
Dependent Claim
10 words
The antiulcer drug of claim 1 further comprising a desintegrator.
Claim 11
Dependent Claim
21 words
The antiulcer drug of claim 8, wherein the desintegrator is selected from the group consisting of crystalline cellulose and carboxymethyl cellulose.
Claim 12
Dependent Claim
10 words
The antiulcer drug of claim 1 further comprising an emollient.
Claim 13
Dependent Claim
20 words
The antiulcer drug of claim 10, wherein the emollient is selected from the group consisting of talc, and magnesium stearate.
Claim 14
Dependent Claim
12 words
The antiulcer drug of claim 1 further comprising a fluidity improving substrate.
Claim 15
Dependent Claim
16 words
The antiulcer drug of claim 12, wherein the fluidity improving substrate is light anhydrous silicic acid.
Claim 16
Dependent Claim
10 words
The antiulcer drug of claim 1 in unit dosage form.
Claim 17
Dependent Claim
16 words
The antiulcer drug of claim 14, wherein Ikarugamycin is present in an amount between 0.01-500 mg/kg.
Claim 18
Dependent Claim
21 words
The method for treating or preventing ulcers of claim 2, wherein Ikarugamycin is administered in an amount of 0.01-500 mg/kg daily.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-02-26 | 1988-08-27 | 1989-02-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-02-26 | 1992-08-27 | 1993-02-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-02-26 | 1996-08-27 | 1997-02-26 | $7700.00 | Window Closed / Lapsed |